Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia (CLL): Preliminary data.

被引：0
|
作者：
Cazin, B
Binet, JL
Divine, M
Lepretre, S
Lederlin, P
Travade, P
Lemaire, G
Guibon, O
机构：
[1] CHU Lille, F-59037 Lille, France
[2] CHU, Paris, France
[3] CHU, Creteil, France
[4] CHU, Rouen, France
[5] CHU, Nancy, France
[6] CHU, Clermont Ferrand, France
[7] Schering SA, Dardilly, France
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2218
引用
收藏
页码：515A / 515A
页数：1
相关论文
共 50 条
  • [1] Oral fludarabine and cyclophosphamide in previously untreated CLL: Preliminary data on 59 pts.
    Cazin, B
    Maloum, K
    Divine, M
    Lepretre, S
    Travade, P
    Delmer, A
    Jaubert, J
    Lederlin, P
    Dreyfus, B
    Leporrier, M
    Harousseau, JL
    Grosbois, B
    Maloisel, F
    Eghbali, H
    Dumontet, C
    Benichou, J
    Guibon, O
    BLOOD, 2001, 98 (11) : 772A - 772A
  • [2] Oral fludarabine and cyclophosphamide in previously untreated CLL: Preliminary data on 75 pts.
    Cazin, B
    Maloum, K
    Divine, M
    Lepretre, S
    Travade, P
    Delmer, A
    Jaubert, J
    Lederlin, P
    Dreyfus, B
    Leporrier, M
    Harousseau, IL
    Grosbois, B
    Maloisel, F
    Eghbali, H
    Dumontet, C
    Guyotat, D
    Benichou, J
    Guibon, O
    BLOOD, 2002, 100 (11) : 206A - 206A
  • [3] Fludarabine and cyclophosphamide: A highly active and well tolerated regimen for patients with previously untreated chronic lymphocytic leukemia (CLL).
    Flinn, IW
    Byrd, JC
    Morrison, C
    Jamison, J
    Miller, C
    Christie, RJ
    Gore, S
    Burke, P
    Vogelsang, G
    Grever, MR
    BLOOD, 1998, 92 (10) : 104A - 104A
  • [4] Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL).
    Wierda, W. G.
    Kipps, T. J.
    Duerig, J.
    Griskevicius, L.
    Stilgenbauer, S.
    Mayer, J.
    Gorczyca, M.
    Andersen, M.
    Nielsen, T.
    Russell, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Early results of modified fludarabine, cyclophosphamide, and rituximab (mFCR) for patients with previously untreated advanced chronic lymphocytic leukemia (CLL).
    Tarhini, A. A.
    Land, S.
    Lim, F.
    Kiefer, G. J.
    Pietragallo, L.
    Pinkerton, R. A.
    Sulecki, M.
    Meisner, D.
    Schaefer, P. M.
    Foon, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 360S - 360S
  • [6] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [7] Cost-effectiveness of rituximab, fludarabine, and cyclophosphamide (R-FC) in patients with previously untreated chronic lymphocytic leukemia (CLL)
    Hornberger, J. C.
    Reyes, C. M.
    Shewade, A.
    Friedmann, M.
    Chan, L.
    Gutierrez, H.
    Satram-Hoang, S.
    Lerner, S.
    Keating, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia
    Izutsu, Koji
    Kinoshita, Tomohiro
    Takizawa, Jun
    Fukuhara, Suguru
    Yamamoto, Go
    Ohashi, Yasuo
    Suzumiya, Junji
    Tobinai, Kensei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 408 - 415
  • [9] Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia
    Rossi, JF
    Van Hoof, A
    De Boeck, K
    Johnson, SA
    Bron, D
    Foussard, C
    Lister, TA
    Berthou, C
    Kramer, MHH
    Littlewood, TJ
    Marcus, RE
    Deconinck, E
    Montillo, M
    Guibon, O
    Tollerfield, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1260 - 1267
  • [10] Update of results of the combination of fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Manero, GG
    O'Brien, S
    Cortes, J
    Faderl, S
    Giles, F
    Albitar, M
    Lerner, S
    Kantarjian, H
    Keating, M
    BLOOD, 2001, 98 (11) : 633A - 633A
12345